Advances in personalized gastroenterology and hepatology 2016

Molecular and cell biology have resulted in major advances in our understanding of disease pathogenesis as well as in novel strategies for the diagnosis, therapy and prevention of human diseases. Based on modern molecular, genetic, epigenetic microbiologic and biochemical analyses it is, on the one...

Full description

Bibliographic Details
Main Author: E. Blum Hubert
Format: Article
Language:Russian
Published: Gastro LLC 2018-08-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
Online Access:https://www.gastro-j.ru/jour/article/view/54
id doaj-0e2a669ce7aa404cb6794ae9a42aa825
record_format Article
spelling doaj-0e2a669ce7aa404cb6794ae9a42aa8252021-07-28T13:06:04ZrusGastro LLCРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии1382-43762658-66732018-08-0126341010.22416/1382-4376-2016-26-3-4-1054Advances in personalized gastroenterology and hepatology 2016E. Blum Hubert0Freiburg University HospitalMolecular and cell biology have resulted in major advances in our understanding of disease pathogenesis as well as in novel strategies for the diagnosis, therapy and prevention of human diseases. Based on modern molecular, genetic, epigenetic microbiologic and biochemical analyses it is, on the one hand, possible to identify disease-related point mutations and single nucleotide polymorphisms in the context of genomewide association analyses (GWAS). On the other hand, using high throughput array and other technologies, it is possible to simultaneously analyze thousands of genes (DNA) or gene products (RNA and proteins), resulting in an individual gene or gene expression profile (‘signature’) or to characterize the individual microbiome and its pathogenetic potential. Such data increasingly allow to define the individual disease predisposition or risk and to predict disease prognosis as well as the efficacy of therapeutic strategies in the individual patient (‘personalized medicine’). All these aspects have greatly contributed to the recent advances in the diagnosis, treatment and prevention of human diseases.https://www.gastro-j.ru/jour/article/view/54структура человеческого геномаполногеномное ассоциативное сканированиепроект по исследованию микробиома человекапрофиль генной экспрессиииндивидуализированная противоопухолевая терапияблокада иммунных контрольных точек
collection DOAJ
language Russian
format Article
sources DOAJ
author E. Blum Hubert
spellingShingle E. Blum Hubert
Advances in personalized gastroenterology and hepatology 2016
Российский журнал гастроэнтерологии, гепатологии, колопроктологии
структура человеческого генома
полногеномное ассоциативное сканирование
проект по исследованию микробиома человека
профиль генной экспрессии
индивидуализированная противоопухолевая терапия
блокада иммунных контрольных точек
author_facet E. Blum Hubert
author_sort E. Blum Hubert
title Advances in personalized gastroenterology and hepatology 2016
title_short Advances in personalized gastroenterology and hepatology 2016
title_full Advances in personalized gastroenterology and hepatology 2016
title_fullStr Advances in personalized gastroenterology and hepatology 2016
title_full_unstemmed Advances in personalized gastroenterology and hepatology 2016
title_sort advances in personalized gastroenterology and hepatology 2016
publisher Gastro LLC
series Российский журнал гастроэнтерологии, гепатологии, колопроктологии
issn 1382-4376
2658-6673
publishDate 2018-08-01
description Molecular and cell biology have resulted in major advances in our understanding of disease pathogenesis as well as in novel strategies for the diagnosis, therapy and prevention of human diseases. Based on modern molecular, genetic, epigenetic microbiologic and biochemical analyses it is, on the one hand, possible to identify disease-related point mutations and single nucleotide polymorphisms in the context of genomewide association analyses (GWAS). On the other hand, using high throughput array and other technologies, it is possible to simultaneously analyze thousands of genes (DNA) or gene products (RNA and proteins), resulting in an individual gene or gene expression profile (‘signature’) or to characterize the individual microbiome and its pathogenetic potential. Such data increasingly allow to define the individual disease predisposition or risk and to predict disease prognosis as well as the efficacy of therapeutic strategies in the individual patient (‘personalized medicine’). All these aspects have greatly contributed to the recent advances in the diagnosis, treatment and prevention of human diseases.
topic структура человеческого генома
полногеномное ассоциативное сканирование
проект по исследованию микробиома человека
профиль генной экспрессии
индивидуализированная противоопухолевая терапия
блокада иммунных контрольных точек
url https://www.gastro-j.ru/jour/article/view/54
work_keys_str_mv AT eblumhubert advancesinpersonalizedgastroenterologyandhepatology2016
_version_ 1721277020892037120